EPA and DHA Market Report and Forecast 2025-2034

The global EPA and DHA market is expected to grow at a CAGR of 8.00% during the forecast period of 2025-2034.

The Health Benefits of EPA and DHA are Augmenting the Growth of the Market

The global market for EPA and DHA is being driven by the rising consumer demand for high-quality supplements owing to busy lifestyles. Omega-3 supplements contain a combination of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), which have many health benefits. One of the major factors enhancing the growth of the market is the increasing incidences of cardiovascular diseases due to unhealthy consumption of food, lack of exercise, and perpetually increasing levels of stress.

A combination of EPA and DHA can significantly aid in reducing the risks of adverse heart diseases, including heart attack, stroke, and heart failure. This has been augmenting the growth of the market. Moreover, the market growth can also be associated with the rise in disposable incomes and the subsequent willingness to spend on clean label products for a healthy life. Increasing awareness about the importance of Omega-3 on immunity and cardiovascular health, especially amidst the COVID-19 pandemic, led to an increment in the growth of the market.

EPA and DHA: Market Segmentation

Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are a combination of Omega-3 supplements, which are predominantly found in oily fish like salmon, mackerel, and tuna. These supplements are rich in proteins and offer many benefits to human and animal health.

Market Breakup by Type

• Eicosapentaenoic Acid (EPA)
• Docosahexaenoic Acid (DHA)

Market Breakup by Form

• Triglycerides
• Ethyl Esters

Market Breakup by Source

• Fish Oil
• Algae Oil
• Krill Oil
• Others

Market Breakup by Application

• Infant Formulae
• Dietary Supplements
• Fortified Food and Beverages
• Pharmaceuticals
• Others

Market Breakup by Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

DHA Segment is Expected to Grow at a Significant Rate During the Forecast Period

Based on type, the docosahexaenoic acid (DHA) segment is expected to grow significantly in the coming years. This is attributable to the many health benefits of DHA on infant health and the resultant incorporation of DHA in infant formulae. DHA is a rich source of protein, which is also found in breast milk and has tremendous health benefits on the health of a newborn. Due to the low presence of DHA in mothers owing to working populations, unhealthy lifestyles, and stress, among others, manufacturers of baby food are actively using DHA as a primary ingredient, thereby stimulating the market growth. In addition to this, Omega-3 plays a substantial role in improving memory, controlling ADHD, and providing immunity. As a result of inflating disposable incomes and improving living standards, the willingness to spend on a nutrition-rich diet for infant health is stimulating the market growth.

Apart from this, the potential benefits of DHA on treating type-2 diabetes, dementia, and cardiovascular health amongst adults is also expected to contribute to the growth of the segment. DHA ingredients are also widely used for improving eyesight, preventing eye diseases, and for the treatment and prevention of depression by promoting healthy mood. These factors are hence predicted to bolster the overall growth of the market in the coming years.

Key Industry Players in the Global EPA and DHA Market

The report presents a detailed analysis of the following key players in the global EPA and DHA market, looking into their capacity, market share, and latest developments like capacity expansions, plant turnabouts and mergers and acquisitions:

• Koninklijke DSM NV
• Corbion N.V.
• BASF SE
• The Archer Daniels Midland Company
• Croda International Plc
• Others

The comprehensive report looks at the micro and macro aspects of the industry. The report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of the Porter’s Five Forces Model.